AD

9-Cyclopentyl-2-({2-methoxy-4-[(1-methyl-4-piperidinyl)oxy]phenyl}amino)-7-methyl-7,9-dihydro-8H-purin-8-one(CAS: 1124329-14-1)

9-Cyclopentyl-2-({2-methoxy-4-[(1-methyl-4-piperidinyl)oxy]phenyl}amino)-7-methyl-7,9-dihydro-8H-purin-8-one
CAS Number

Related Products

Other Suppliers for 9-Cyclopentyl-2-({2-methoxy-4-[(1-methyl-4-piperidinyl)oxy]phenyl}amino)-7-methyl-7,9-dihydro-8H-purin-8-one

Basic Information

Molecular Formula
C24H32N6O3
Molecular Weight
452.56 g/mol

Physical Properties

Boiling Point
621.04 °C at 760 mmHg

Chemical Identifiers

SMILES
COc1cc(ccc1Nc1ncc2c(n1)n(C1CCCC1)c(=O)n2C)OC1CCN(CC1)C
InChIKey
YUKWVHPTFRQHMF-UHFFFAOYSA-N

Database References

MDL Number
MFCD18384959

FAQ

The compound 9-Cyclopentyl-2-({2-methoxy-4-[(1-methyl-4-piperidinyl)oxy]phenyl}amino)-7-methyl-7,9-dihydro-8H-purin-8-one (CAS: 1124329-14-1) is subject to regulatory guidelines under the Globally Harmonized System of Classification and Labeling of Chemicals (GHS), REACH regulations, and FDA/EPA requirements. Specific GHS classifications include handling instructions for hazardous properties such as reactivity and health hazards. Under REACH, it may require a safety data sheet (SDS) and registration if used in quantities above thresholds. FDA and EPA regulations ensure its safe use and disposal in pharmaceutical and industrial applications.
In synthesis, alternatives to 9-Cyclopentyl-2-({2-methoxy-4-[(1-methyl-4-piperidinyl)oxy]phenyl}amino)-7-methyl-7,9-dihydro-8H-purin-8-one (CAS: 1124329-14-1) may include analogs or isomers with similar pharmacological properties, such as 9-Cyclopentyl-2-({2-methoxy-4-[(1-ethyl-4-piperidinyl)oxy]phenyl}amino)-7-methyl-7,9-dihydro-8H-purin-8-one. Common alternative reagents might include different piperidine derivatives or modifications to the purine ring structure, which can offer similar or distinct biological activities.
The market trend for 9-Cyclopentyl-2-({2-methoxy-4-[(1-methyl-4-piperidinyl)oxy]phenyl}amino)-7-methyl-7,9-dihydro-8H-purin-8-one (CAS: 1124329-14-1) reflects growing interest in its potential use in pharmaceutical applications. Research is focused on understanding its mechanisms of action and exploring its efficacy in treating various diseases, particularly in anti-inflammatory and immunomodulatory fields. Market trends show increasing demand from pharmaceutical companies and academic institutions, driving innovation and development in this compound.
Waste containing 9-Cyclopentyl-2-({2-methoxy-4-[(1-methyl-4-piperidinyl)oxy]phenyl}amino)-7-methyl-7,9-dihydro-8H-purin-8-one (CAS: 1124329-14-1) should be handled according to proper waste management procedures. This includes segregating the waste, storing it in a secure container, and labeling it appropriately. For disposal, it is recommended to use professional waste disposal services that can safely incinerate or treat the waste. Environmental precautions should include minimizing exposure to air and water, and following local regulations and guidelines for hazardous waste management to ensure compliance with safety and environmental protection standards.

Safety Notice

Please verify product specifications and safety data before use. Contact the supplier for detailed safety information.

Always follow proper handling procedures

Contact Information

Email

rebertact@163.com